| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
2.102 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
2.102 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
2.102 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
TXN |
TXN, TRDX, TRX, TRX1: Thioredoxin |
2.102 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
GIT1 |
GIT1: ARF GTPase-activating protein GIT1 |
2.102 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
2.102 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
EVL |
IPI00218245 |
2.102 |
Evidence |
|
| AIP |
AIP, XAP2: AH receptor-interacting protein |
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
2.102 |
Evidence |
|
| SGK |
SGK, SGK1: Serine/threonine-protein kinase Sgk1 |
EXOC2 |
IPI00215805 |
2.102 |
Evidence |
|
| BMX |
IPI00514142 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
2.1 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
2.1 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
2.1 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
2.1 |
Evidence |
|
| GLRA1 |
IPI00011565 |
GABRR1 |
IPI00027150 |
2.1 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
2.1 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
2.1 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
2.1 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
2.1 |
Evidence |
|
| PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
SERPINA3 |
IPI00550991 |
2.1 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
2.1 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
2.1 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
LPA |
LPA: Apolipoprotein(a) precursor |
2.1 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
2.1 |
Evidence |
|
| APOE |
APOE: Apolipoprotein E precursor |
CETP |
CETP: Cholesteryl ester transfer protein precursor |
2.1 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
CFI |
CFI, IF: Complement factor I precursor |
2.1 |
Evidence |
|